JO
ATRA icon

John Overdeck’s Atara Biotherapeutics ATRA Stock Holding History

John Overdeck’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,167
Closed -$66.2K – 3030
2023
Q4 		$66.2K Buy
+5,167
New +$120K ﹤0.01% 2974
2023
Q3 		– Sell
-610
Closed -$24.6K – 2949
2023
Q2 		$24.6K Buy
+610
New +$34.5K ﹤0.01% 2892
2023
Q1 		– Sell
-3,705
Closed -$304K – 2956
2022
Q4 		$304K Buy
3,705
+3,232
+683% +$337K ﹤0.01% 2240
2022
Q3 		$45K Buy
+473
New +$53.1K ﹤0.01% 2325
2021
Q4 		– Sell
-9,845
Closed -$4.41M – 4259
2021
Q3 		$4.41M Sell
9,845
-9,493
-49% -$3.4M 0.01% 1331
2021
Q2 		$7.52M Sell
19,338
-18,890
-49% -$6.74M 0.02% 973
2021
Q1 		$13.7M Sell
38,228
-1,592
-4% -$704K 0.04% 574
2020
Q4 		$19.5M Buy
39,820
+18,545
+87% +$8.56M 0.06% 379
2020
Q3 		$6.89M Buy
21,275
+16,529
+348% +$5.63M 0.02% 653
2020
Q2 		$1.73M Buy
4,746
+1,506
+46% +$380K 0.01% 1171
2020
Q1 		$689K Sell
3,240
-6,385
-66% -$2.03M 0.01% 1704
2019
Q4 		$3.96M Buy
9,625
+5,912
+159% +$2.04M 0.01% 1106
2019
Q3 		$1.31M Buy
+3,713
New +$1.39M ﹤0.01% 1755
2015
Q3 		– Sell
-619
Closed -$816K – 2182
2015
Q2 		$816K Buy
+619
New +$710K ﹤0.01% 1793

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

John Overdeck's ATRA Position: Q1 2024 in Review

John Overdeck sold out of Atara Biotherapeutics (ATRA) in Q1 2024, closing a stake of 5,167 shares — an estimated $66.2K sold.

John Overdeck first reported a position in ATRA in Q2 2015 and held it in 14 quarters. The position peaked at $19.5M in Q4 2020. 82 funds tracked by Wall St. Rank hold ATRA as of Q1 2024.

  • John Overdeck reported no remaining Atara Biotherapeutics position as of Q1 2024 after selling out during the quarter.
  • John Overdeck sold 5,167 Atara Biotherapeutics shares in Q1 2024, an estimated $66.2K.
  • John Overdeck first reported a position in Atara Biotherapeutics in Q2 2015 and held it in 14 quarters.
  • John Overdeck's Atara Biotherapeutics position peaked at $19.5M in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.